In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
about
Allopurinol Resistance in Leishmania infantum from Dogs with Disease RelapseClinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine AntimoniateImmunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Dynamics and predictive potential of antibodies against insect-derived recombinant Leishmania infantum proteins during chemotherapy of naturally infected dogs.Visceral leishmaniasis treatment, Italy.Antimony resistance in leishmania, focusing on experimental research.Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania sppAntimony resistance and environment: Elusive links to explore during Leishmania life cycle.Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum.Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis.Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.A complaint from Citizens for Sludge-Free Land.
P2860
Q28552396-F8FD088D-DD37-4335-A007-6D8068CC3FC4Q28552530-9947C165-5909-44F0-9A06-40809D84AF91Q33749424-95F96FD8-51B1-4BE9-BC90-F53A1A200D1FQ33817557-C106CAFE-60FF-4938-A05C-C4CB9328D31FQ34554991-841F097A-D56E-407D-B474-6E54E5FF94B8Q35607561-9F49DF68-99DC-43D6-A8A0-8F523D65C4D7Q36118602-9FA89318-0B53-4484-A3FE-BCC6A8816563Q37390629-AA18639D-751E-4867-9E84-9D9D17E85470Q40367948-97E546F9-AAB5-41F0-B89D-17F5D6C1494EQ40469485-5A3D9D89-5AF3-42E4-BADB-97B9206093C5Q40945954-43AE2321-0F55-475F-A39A-19BE2C7F6F66Q42548785-68409B06-60A7-4080-8B31-E912899B1BEBQ43346557-6C6A0E21-8B9D-4A68-AC5C-A395CDCC50BB
P2860
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
In vitro susceptibility to pen ...... ent with meglumine antimoniate
@nl
In vitro susceptibility to pen ...... nt with meglumine antimoniate.
@ast
In vitro susceptibility to pen ...... nt with meglumine antimoniate.
@en
type
label
In vitro susceptibility to pen ...... ent with meglumine antimoniate
@nl
In vitro susceptibility to pen ...... nt with meglumine antimoniate.
@ast
In vitro susceptibility to pen ...... nt with meglumine antimoniate.
@en
prefLabel
In vitro susceptibility to pen ...... ent with meglumine antimoniate
@nl
In vitro susceptibility to pen ...... nt with meglumine antimoniate.
@ast
In vitro susceptibility to pen ...... nt with meglumine antimoniate.
@en
P2860
P3181
P356
P1433
P1476
In vitro susceptibility to pen ...... nt with meglumine antimoniate.
@en
P2093
Jaume Carrió
Montserrat Portús
P2860
P2888
P3181
P356
10.1186/1471-2210-2-11
P407
P577
2002-05-02T00:00:00Z
P5875
P6179
1031126585